Table 3 Characteristics of IPMN patients stratified by CEA
Variables | CEA ≤ 5.3 ug/L | CEA > 5.3 ug/L | p-Value |
|---|---|---|---|
Age, n(%), y | Â | Â | 0.248 |
 < 60 | 111 (33.3%) | 12 (25.0%) |  |
 ≥ 60 | 222 (66.7%) | 36 (75.0%) |  |
Sex, (n%) | Â | Â | 0.978 |
 Male | 188 (56.5%) | 27 (56.3%) |  |
 Female | 145 (43.5%) | 21 (43.8%) |  |
Location, (n%) | Â | Â | 0.238 |
 Head | 197 (64.6%) | 31 (73.8%) |  |
 Body and tail | 108 (35.4%) | 11 (26.2%) |  |
Tumour grade, (n%) | Â | Â | < 0.001 |
 Low and moderate | 232 (69.7%) | 14 (29.2%) |  |
 High and carcinoma | 101 (30.3%) | 34 (70.8%) |  |
Vascular invasion, (n%) | Â | Â | 0.121 |
 No | 163 (98.2%) | 22 (91.7%) |  |
 Yes | 3 (1.8%) | 2 (8.3%) |  |
Perineural infiltration, (n%) | Â | Â | 0.035 |
 No | 159 (95.8%) | 20 (83.3%) |  |
 Yes | 7 (4.2%) | 4 (16.7%) |  |
Ductal dilation, (n%) | Â | Â | < 0.001 |
 No | 231 (69.4%) | 16 (33.3%) |  |
 Yes | 102 (30.6%) | 32 (66.7%) |  |